Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
7.53
-0.03 (-0.40%)
At close: Jan 27, 2026, 4:00 PM EST
7.65
+0.12 (1.59%)
Pre-market: Jan 28, 2026, 7:00 AM EST
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $590.68 million as of January 28, 2026. Its market cap has decreased by -33.43% in one year.
Market Cap
590.68M
Enterprise Value
343.36M
1-Year Change
-33.43%
Ranking
Category
Stock Price
$7.53
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $590.68M, an increase of 26.34%. That is a compound annual growth rate of 3.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 593.03M | -22.22% |
| Dec 31, 2025 | 762.47M | -18.18% |
| Dec 31, 2024 | 931.93M | 87.18% |
| Dec 29, 2023 | 497.87M | -67.63% |
| Dec 30, 2022 | 1.54B | 21.04% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alpha Tau Medical | 624.13M |
| Lexicon Pharmaceuticals | 621.41M |
| Evommune | 617.87M |
| Gossamer Bio | 611.04M |
| CorMedix | 610.62M |
| LENZ Therapeutics | 606.71M |
| Design Therapeutics | 603.25M |
| Tenax Therapeutics | 600.44M |